Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers Gobburu JV, Agers H, Jusko WJ, Ynddal L Pharmaceutical Research (1999) This PK/PD study in human volunteers documented Ipamorelin's pharmacokinetic profile, showing peak GH concentrations approximately 30-40 minutes post-injection with effects lasting 2-3 hours
A tendon fibroblast finding, for example, belongs to a tendon fibroblast model
However, that evidence applies specifically to the DAC-modified long-acting form, not necessarily to CJC-1295 No DAC / Modified GRF (1-29), which has a shorter duration of action
But, the truth is, your diet is much more effective